≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Oral leukoplakia

Endpoint Browser PheWeb

K11_ORAL_LEUCOPLACIA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

612

4. Check minimum number of events

None

612

5. Include endpoints

None

612

6. Filter based on genotype QC (FinnGen only)

612

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3606 1908 1678
Only index persons 3407 1821 1586
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.05
Only index persons 0.06 0.07 0.06
Median age at first event (years)
Whole population 58.48 60.03 56.73
Only index persons 58.24 59.79 56.47

-FinnGen-

Key figures

All Female Male
Number of individuals 612 328 284
Unadjusted period prevalence (%) 0.12 0.11 0.13
Median age at first event (years) 57.98 57.58 58.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
564
Matched controls
5639
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K13.20
ICD-10 Finland
Idiopathic leukoplakia
+∞
323.0
436
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
77.5
192.7
214
44
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
679.0
160.4
151
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
126.4
128.8
135
14
EKA10
NOMESCO Finland
Biopsy of cheek
48.1
114.5
139
38
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
21.0
80.3
122
73
SAA03
NOMESCO Finland
Extended examination of mouth
4.7
64.6
337
1350
L43.8
ICD-10 Finland
Other lichen planus
21.9
52.7
78
41
ECA20
NOMESCO Finland
Biopsy of gingiva
38.5
51.4
65
19
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
72.9
47.0
53
8
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
104.7
44.5
48
5
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
15.0
43.6
74
56
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
66.9
43.0
49
8
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
9.0
42.2
94
123
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
42.2
276
1194
A07AA02
ATC
nystatin; oral
7.5
41.1
103
162
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
8.6
38.6
88
119
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
31.0
38.5
51
18
SXA10
NOMESCO Finland
Epithel biopsy of mouth
20.3
37.9
57
31
SBA00
NOMESCO Finland
Microbiological examinations
13.4
37.2
66
55
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.8
37.1
90
134
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.4
35.0
227
940
K13.78
ICD-10 Finland
Other change in the oral mucosa
13.5
30.7
54
44
L43.9
ICD-10 Finland
Lichen planus, unspecified
11.8
25.9
48
44
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
94.4
24.9
27
*
SAA02
NOMESCO Finland
Basic examination of mouth
2.5
24.0
376
2486
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
250.1
23.8
24
*
EHA10
NOMESCO Finland
Biopsy of palate
20.6
23.7
35
18
B37.08
ICD-10 Finland
Other candidal stomatitis
23.3
23.3
33
15
A01AB09
ATC
miconazole; local oral
4.0
22.4
97
278
TEA00
NOMESCO Finland
Biopsy of lip
21.1
21.9
32
16
GBB00
NOMESCO Finland
Tracheostomy
15.8
18.6
30
20
SAA01
NOMESCO Finland
Simple examination of mouth
2.2
17.5
398
2911
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
21.7
17.4
25
12
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
43.5
17.4
21
5
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
17.4
252
1507
A01AC01
ATC
triamcinolone; local oral
10.2
16.4
32
33
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
164.3
15.6
16
*
ZXC10
NOMESCO Finland
Use of laser
6.7
15.3
39
62
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.2
14.9
58
150
WX110
NOMESCO Finland
Local anesthesy
2.1
14.8
386
2875
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
19.0
14.8
22
12
SXC03
NOMESCO Finland
Other oral or dental procedure
11.3
14.6
27
25
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.0
14.4
91
345
EKB00
NOMESCO Finland
Excision of lesion of cheek
19.8
14.3
21
11
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.0
14.3
46
98
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
14.9
14.2
23
16
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.4
13.9
28
31
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
13.6
13
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
143.3
13.5
14
*
EDB00
NOMESCO Finland
Partial excision of mandible
51.2
12.9
15
*
L43.3
ICD-10 Finland
Subacute (active) lichen planus
38.4
12.3
15
*
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
38.4
12.3
15
*
K05.31
ICD-10 Finland
Periodontitis pronounced
2.9
12.2
77
288
L43.0
ICD-10 Finland
Hypertrophic lichen planus
18.5
12.1
18
10
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
47.7
11.9
14
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
12.1
11.9
21
18
EJB40
NOMESCO Finland
Hemiglossectomy
30.7
11.7
15
5
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
122.4
11.5
12
*
EJ2S1
NOMESCO Finland
Photography of oral mucosa
122.4
11.5
12
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.5
11.2
53
163
J02AC01
ATC
fluconazole; systemic
1.9
11.2
223
1444
A01AB04
ATC
amphotericin B; local oral
3.5
10.7
50
152
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.9
10.7
201
1268
Z01.2
ICD-10 Finland
Dental examination
1.9
10.5
223
1468
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
33.2
10.4
13
*
SXC05
NOMESCO Finland
Other oral or dental procedure
3.9
10.2
41
110
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.9
10.2
63
234
SBB10
NOMESCO Finland
Teeth copy
3.6
10.0
45
133
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
40.8
10.0
12
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.3
9.6
22
31
D07AC01
ATC
betamethasone; topical
1.8
9.5
202
1317
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
17.9
9.4
14
8
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
8.3
9.4
20
25
EBA00
NOMESCO Finland
Extraction of tooth
1.8
9.1
178
1127
K12.10
ICD-10 Finland
Stomatitis NOS
15.9
9.1
14
9
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
24.5
8.9
12
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
8.9
267
1934
D07AD01
ATC
clobetasol; topical
2.1
8.9
105
547
K12.18
ICD-10 Finland
Other forms of stomatitis
14.3
8.7
14
10
EBA10
NOMESCO Finland
Surgical removal of tooth
2.6
8.6
64
265
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
28.0
8.5
11
*
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
91.4
8.4
9
*
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
+∞
8.4
8
*
K13.6
ICD-10 Finland
Irritative hyperplasia of oral mucosa
9.1
8.1
16
18
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
8.0
103
558
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
8.6
7.9
16
19
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
4.1
7.8
29
74
SPA02
NOMESCO Finland
Preparation for dental prosthetics
5.7
7.7
21
38
K05.30
ICD-10 Finland
Periodontitis complex
2.3
7.7
75
359
N07BA03
ATC
varenicline; oral
3.3
7.7
37
117
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
18.7
7.6
11
6
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.9
7.6
20
35
K02.1
ICD-10 Finland
Caries of dentine
1.6
7.6
280
2116
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
6.1
7.4
19
32
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
81.1
7.4
8
*
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
81.1
7.4
8
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.1
7.3
13
12
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
7.3
7
*
EAA10
NOMESCO Finland
Excision of lesion of lip
6.4
7.3
18
29
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
20.3
7.2
10
5
EBB15
NOMESCO Finland
Insertion of dental implant abutment
12.2
7.1
12
10
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.8
7.0
123
743
XQ802
NOMESCO Finland
Epicutan test
3.7
6.8
28
79
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
6.7
99
559
ECA30
NOMESCO Finland
Excision of lesion of gingiva
7.9
6.6
14
18
K14.61
ICD-10 Finland
Glossodynia
10.2
6.6
12
12
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
6.5
48
198
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
70.6
6.4
7
*
8070/3-C06.9
ICD-O-3
Squamous cell carcinoma, NOS, of mouth, NOS
70.6
6.4
7
*
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
14.5
6.4
10
7
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.3
150
989
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
7.1
6.2
14
20
J01CE02
ATC
phenoxymethylpenicillin; oral
1.6
6.2
351
2890
EBB10
NOMESCO Finland
Insertion of dental implant
7.8
6.1
13
17
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
6.1
280
2191

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
67
63
11.82
62.95
2.5
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
126
642
2.21
12.95
1.7
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
82
381
2.33
10.39
4.9
5.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
231
1617
1.69
8.54
2.4
2.1
u/l
181.1
220.5
0.33
220
1522
(3007853) Bacteria identified in Skin by Aerobe culture
110
617
1.95
8.52
1.9
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
163
1047
1.76
8.17
1.7
1.7
nmol/l
1147.0
1224.2
0.47
127
782
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
17
7.18
8.02
5.9
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
307
2341
1.62
7.94
5.0
4.6
g/l
35.0
35.2
0.27
287
2189
(3013826) Glucose [Moles/volume] in Serum or Plasma
386
3117
1.65
7.89
5.1
4.7
mmol/l
6.9
6.8
0.80
370
2921
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
118
698
1.86
7.74
4.5
4.8
%
31.2
31.9
0.28
81
458
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
116
694
1.83
7.31
9.1
7.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
520
4595
1.88
7.20
5.6
4.7
mu/l
2.0
2.2
0.46
475
4143
(3019225) pH of Specimen
94
530
1.91
7.12
3.7
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
292
2248
1.57
6.94
6.9
9.2
inr
1.3
1.2
0.34
45
623
(3008152) Bicarbonate [Moles/volume] in Arterial blood
70
359
2.07
6.92
7.7
7.3
mmol/l
24.5
24.6
0.07
65
340
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
348
2804
1.56
6.65
6.1
6.4
umol/l
11.1
11.5
0.19
331
2664
(40768804) Tissue Pathology biopsy report
266
2021
1.56
6.60
2.8
2.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
118
732
1.76
6.55
26.9
23.0
inr
1.5
1.3
0.63
16
92
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
310
2442
1.55
6.50
7.0
5.8
mmol/l
1.2
1.2
1.26
277
2208
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
48
218
2.30
6.41
2.0
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
45
202
2.33
6.18
1.6
1.6
—
—
—
0
0
(3013512) EKG study
222
1640
1.55
6.13
4.1
4.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
329
2648
1.52
6.11
8.0
6.6
mmol/l
1.2
1.2
1.63
290
2248
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
304
2407
1.52
6.09
4.7
4.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
178
1271
1.56
5.63
2.7
2.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
439
3794
1.56
5.61
5.3
4.2
mm/h
14.1
13.1
0.67
401
3478
(3003396) Base excess in Arterial blood by calculation
101
636
1.70
5.27
6.6
7.0
mmol/l
1.7
1.2
0.74
73
508
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
69
388
1.88
5.26
1.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
271
2142
1.48
5.21
3.7
3.9
ng/l
28.4
55.4
1.05
210
1602
(3023368) Bacteria identified in Blood by Culture
200
1492
1.51
5.10
4.5
4.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
101
642
1.69
5.08
6.5
6.9
kpa
5.1
5.1
0.11
96
616
(3027801) Oxygen [Partial pressure] in Arterial blood
101
642
1.69
5.08
6.5
6.9
kpa
11.8
12.0
0.16
96
618
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
82
492
1.77
5.07
2.2
2.6
ug/l
5.7
6.5
0.12
70
427
(42870588) Differential panel, method unspecified - Blood
222
1694
1.49
5.06
6.2
5.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
276
2217
1.45
4.75
2.2
2.0
pmol/l
94.2
95.3
0.16
151
1111
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
379
3234
1.45
4.68
3.7
3.2
u/l
48.0
51.5
0.47
348
2985
(3012095) Magnesium [Moles/volume] in Serum or Plasma
122
830
1.59
4.68
3.6
3.4
mmol/l
0.8
0.8
0.17
115
772
(1761868) Lipid panel - Serum or Plasma
120
1694
0.64
4.66
2.8
3.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
433
3794
1.48
4.63
4.6
3.9
pmol/l
15.2
14.9
1.10
390
3389
(3003458) Phosphate [Moles/volume] in Serum or Plasma
104
683
1.63
4.60
6.3
5.1
mmol/l
1.0
1.0
0.14
96
626
(3017732) Neutrophils [#/volume] in Blood
60
337
1.87
4.60
2.9
2.9
e9/l
5.0
4.1
0.85
46
255
(3006315) Basophils [#/volume] in Blood
305
2516
1.42
4.44
6.3
5.6
e9/l
0.0
0.0
1.41
273
2169
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
455
4044
1.49
4.38
8.5
7.7
u/l
80.6
78.9
0.35
431
3774
(3031040) Bacteria [#/volume] in Urine by Automated count
393
3411
1.43
4.18
5.4
4.6
e6/l
1452.8
2899.8
—
6
56
(3019150) Specific gravity of Urine by Refractometry
153
1130
1.47
3.97
4.9
4.1
kg/l
1.0
1.0
0.30
22
161
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
538
4993
1.64
3.91
20.0
15.3
mg/l
25.2
24.5
0.17
464
4016
(3013115) Eosinophils [#/volume] in Blood
309
2594
1.39
3.87
6.6
5.8
e9/l
0.2
0.2
0.39
277
2283
(3037467) Urinalysis macro (dipstick) panel - Urine
400
3510
1.40
3.81
5.1
4.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
70
436
1.68
3.80
2.9
3.0
ng/l
212.6
214.5
0.02
65
396
(3001604) Monocytes [#/volume] in Blood
299
2505
1.38
3.75
6.4
5.6
e9/l
0.6
0.6
0.60
268
2151
(3019198) Lymphocytes [#/volume] in Blood
304
2556
1.38
3.72
6.4
5.6
e9/l
1.8
2.0
0.67
274
2244
(3013650) Neutrophils [#/volume] in Blood by Automated count
345
2962
1.38
3.70
8.5
9.1
e9/l
4.5
4.1
1.43
310
2605
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
73
2.65
3.67
1.7
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
124
892
1.49
3.65
2.1
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
212
1687
1.39
3.60
2.8
2.5
u/l
58.4
56.2
0.17
205
1561
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
74
2.62
3.58
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
74
2.62
3.58
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
74
2.62
3.58
1.8
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
210
1671
1.39
3.56
2.8
2.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
169
1299
1.42
3.49
2.2
2.1
mg/l
2.9
3.2
0.55
142
1114
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
75
2.58
3.49
1.8
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
254
2092
1.37
3.46
2.6
2.3
nmol/l
76.8
78.1
0.36
227
1840
(3019550) Sodium [Moles/volume] in Serum or Plasma
559
5278
1.68
3.30
22.9
17.8
mmol/l
139.1
139.7
4.36
546
5143
(3015377) Calcium [Moles/volume] in Serum or Plasma
224
1820
1.36
3.29
2.8
3.4
mmol/l
2.4
2.4
0.77
190
1583
(4035726)
70
459
1.59
3.13
1.6
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
285
1.74
3.12
8.2
9.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
77
517
1.56
3.11
2.6
1.8
%
1.7
1.5
1.11
66
440
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
74
2.48
3.07
1.8
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
34
3.28
3.07
2.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
34
3.28
3.07
2.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
12
5.89
3.03
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
70
464
1.57
3.00
4.0
3.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
137
1041
1.41
2.99
1.2
1.2
u/ml
1.2
1.4
0.21
40
281
(3007164) IgA [Mass/volume] in Serum or Plasma
124
927
1.42
2.96
1.3
1.4
g/l
2.5
2.6
0.26
75
545
(3018010) Neutrophils/100 leukocytes in Blood
279
2375
1.32
2.91
6.5
5.6
%
58.9
57.5
1.17
259
2214
(3023103) Potassium [Moles/volume] in Serum or Plasma
558
5293
1.61
2.89
22.9
17.8
mmol/l
4.0
4.0
1.46
544
5154
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
135
1031
1.40
2.85
4.9
3.9
ng/l
1741.9
330.3
0.48
108
832
(36660697) Celiac disease serology panel - Serum
56
358
1.62
2.79
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
28
146
1.96
2.74
3.5
3.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
277
2372
1.31
2.71
7.4
6.0
%
8.5
8.8
0.85
258
2213
(3042936) Bacteria identified in Isolate by Culture
109
809
1.42
2.70
2.2
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
548
5190
1.53
2.70
19.7
14.5
—
—
—
0
0
(4010399)
61
402
1.57
2.69
1.5
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
24
3.79
2.68
2.1
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
275
2360
1.30
2.62
6.8
5.7
%
2.7
2.9
0.54
258
2191
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
98
719
1.43
2.59
2.4
2.3
%
20.1
22.2
0.94
74
619
(3002030) Lymphocytes/100 leukocytes in Blood
280
2412
1.30
2.58
7.1
5.9
%
25.8
27.3
1.35
260
2235
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
136
1.95
2.54
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
279
1.66
2.54
2.4
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
132
1.93
2.39
1.6
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
509
4781
1.38
2.36
6.7
6.2
mmol/mol
41.5
40.5
0.54
467
4400
(3001122) Ferritin [Mass/volume] in Serum or Plasma
238
2027
1.28
2.34
2.9
2.7
ug/l
138.3
138.3
0.00
215
1842
(3026008) Bacteria identified in Urine by Culture
197
1641
1.30
2.29
3.7
3.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
82
596
1.43
2.29
3.1
4.1
ug/l
99.2
29.2
0.37
69
495
(3022096) Basophils/100 leukocytes in Blood
265
2297
1.27
2.24
6.9
5.7
%
0.7
0.7
0.69
247
2136
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
62
429
1.50
2.22
2.3
2.7
ml/min/173m2
65.4
63.9
0.11
28
183
(40761536) Microorganisms panel - Urine sediment
24
422
0.55
2.20
2.9
3.9
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
24
3.36
2.18
1.3
1.9
ug/l
79.1
66.3
—
8
24
(3023520) Reticulocytes [#/volume] in Blood
65
457
1.47
2.16
2.0
2.8
e9/l
71.2
71.0
0.02
54
357
(3048879) Bone marrow aspiration report
6
14
4.32
2.15
2.2
2.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
25
3.23
2.10
10.6
11.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
20
3.53
2.06
1.0
2.7
u/ml
764.6
655.0
—
7
20
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
51
345
1.52
2.05
1.5
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
41
265
1.59
2.01
3.8
3.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
105
1.94
1.97
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
105
1.94
1.97
1.6
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
507
4797
1.33
1.93
4.6
4.2
mmol/l
1.3
1.3
0.00
455
4333
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
52
2.33
1.88
3.7
2.6
%
73.3
59.3
—
7
38
(3051611) Lipemic interference index of Serum or Plasma
12
52
2.33
1.88
3.3
3.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
523
4977
1.35
1.87
5.2
4.9
mmol/l
6.0
6.0
0.02
480
4494
(3022689) Creatine [Moles/volume] in Urine
5
12
4.19
1.82
1.4
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
101
1.91
1.82
1.1
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
571
5520
1.51
1.81
29.3
22.4
pg
30.6
30.4
2.33
559
5432
(3007461) Platelets [#/volume] in Blood
571
5520
1.51
1.81
29.4
22.5
e9/l
249.3
245.9
0.53
555
5376
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
423
1.44
1.80
4.1
3.5
ng/l
74.2
81.2
0.49
49
379
(3010813) Leukocytes [#/volume] in Blood
571
5521
1.51
1.80
29.5
22.5
e9/l
6.9
6.8
1.15
555
5357
(3026361) Erythrocytes [#/volume] in Blood
571
5521
1.51
1.80
29.5
22.5
e12/l
4.4
4.5
4.01
555
5357
(3024731) MCV [Entitic volume]
571
5521
1.51
1.80
29.3
22.4
fl
92.0
91.5
2.38
559
5433
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
109
1.86
1.79
1.4
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
571
5522
1.51
1.79
29.6
22.6
g/l
133.2
134.9
1.98
561
5432
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
147
1.73
1.76
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
191
2211
0.80
1.76
9.2
9.9
e9/l
0.0
0.0
0.34
157
1815
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
23
132
1.77
1.76
2.3
2.5
mg/l
1.6
1.6
0.01
23
122
(3002385) Erythrocyte distribution width [Ratio]
380
4093
0.81
1.72
22.3
18.8
%
13.9
13.8
0.82
372
4014
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
535
5125
1.35
1.68
5.7
5.3
mmol/l
2.6
2.7
2.54
494
4659
(3027945) Reticulocytes/100 erythrocytes in Blood
79
605
1.35
1.66
2.2
2.6
%
1.9
1.8
0.07
71
549
(42529406) Shigella sp [Presence] in Stool by Culture
25
150
1.70
1.66
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
63
2.09
1.60
4.8
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
29
443
0.64
1.59
3.8
3.7
mmol/l
1.2
1.2
0.26
24
393
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
556
5367
1.39
1.58
12.9
11.0
u/l
25.1
25.9
0.81
533
5161
(3020891) Body temperature
34
224
1.55
1.58
6.8
4.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
75
576
1.34
1.55
2.0
2.2
ug/g
183.1
142.4
0.26
65
452
(3026493) Urate [Moles/volume] in Serum or Plasma
161
1366
1.24
1.55
2.6
2.6
umol/l
2289.6
7154.4
1.33
137
1161
(3024980) IgG subclass 4 [Mass/volume] in Serum
14
71
1.99
1.55
1.6
2.0
g/l
0.6
1.1
—
9
57
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
44
2.29
1.54
1.3
1.1
—
1.6
—
0
18
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
15
3.35
1.52
4.8
7.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
147
1.66
1.49
1.2
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
22
2.74
1.43
4.2
15.2
nmol/l
576.1
937.8
—
6
22
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
194
1694
1.21
1.41
2.6
3.1
ng/l
1245.4
1325.5
0.15
166
1461
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
2.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
2.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
41
2.21
1.37
3.7
1.7
%
8.3
11.6
—
9
41
(3035637) Corticotropin [Mass/volume] in Plasma
10
47
2.15
1.34
1.2
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
20
121
1.67
1.32
2.5
3.1
nmol/l
0.8
0.9
1.02
13
100
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
185
1.54
1.31
3.8
3.8
mg/l
32.0
32.1
0.00
23
148
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
76
1.86
1.30
2.1
3.0
—
782.7
—
0
10
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
62
1.95
1.28
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
520
5003
1.26
1.26
5.2
4.7
mmol/l
4.5
4.6
1.05
475
4584
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
163
1.56
1.25
1.5
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
191
1683
1.20
1.25
3.6
3.1
mmol/l
6.6
7.3
2.00
163
1395
(40768443) Skin Pathology biopsy report
32
221
1.47
1.24
1.2
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
34
238
1.45
1.23
2.0
2.1
ug/l
0.8
2.7
0.89
28
215
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
516
4964
1.25
1.23
5.2
4.6
mmol/l
1.5
1.5
0.24
474
4510
(3006653) Thiamine [Moles/volume] in Blood
5
19
2.64
1.22
1.2
1.5
nmol/l
134.6
140.7
—
5
19
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
197
1.50
1.21
1.2
2.1
g/l
3.4
3.1
0.74
21
158
(3020564) Creatinine [Moles/volume] in Serum or Plasma
552
5357
1.31
1.19
22.8
18.2
umol/l
77.5
78.6
0.33
552
5357
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
38
2.12
1.18
4.1
3.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
64
1.89
1.18
4.5
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
195
1729
1.19
1.18
4.0
4.0
mg/mmol
3.0
8.4
5.05
115
1085
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
27
182
1.51
1.18
3.9
3.8
—
1.9
—
0
22
(3045142) Bone marrow Pathology biopsy report
11
57
1.95
1.17
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
83
675
1.27
1.17
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
20
2.51
1.15
5.6
3.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
113
0.44
1.13
1.2
1.2
e6/l
18.8
21.7
—
5
85
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
113
0.44
1.13
1.2
1.2
e6/l
10.8
1123.0
—
5
88
(3037756) Immunofixation for Serum or Plasma
20
127
1.59
1.12
2.0
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
58
1.91
1.12
1.1
1.3
nmol/l
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
232
0.59
1.12
1.4
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
75
606
1.27
1.12
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
51
1.98
1.11
2.1
2.2
—
—
—
0
0
(3009343) pH of Capillary blood
47
356
1.35
1.11
4.0
3.4
—
7.4
—
0
42
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
31
2.27
1.10
1.7
3.0
%
13.0
13.3
—
7
31
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
1046
0.80
1.10
2.7
3.0
ug/l
0.6
0.7
0.81
49
688
(3021960) Folate [Moles/volume] in Serum or Plasma
151
1317
1.19
1.10
1.7
1.5
nmol/l
19.2
20.6
0.63
132
1103
(3005719) IgG [Mass/volume] in Serum or Plasma
52
401
1.32
1.09
2.8
2.8
g/l
11.7
10.6
0.67
47
369
(3012516) Albumin [Mass/volume] in Urine
184
1635
1.18
1.08
3.6
3.2
mg/l
390.2
287.8
0.10
112
1046
(3011288) Drugs identified in Urine by Screen method
10
52
1.94
1.06
9.1
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
212
1.44
1.06
1.2
2.1
g/l
3.9
3.8
0.16
20
156
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
212
1.44
1.06
1.2
2.1
g/l
7.6
7.5
0.04
22
162
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
212
1.44
1.06
1.2
2.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
333
1.35
1.05
4.1
3.5
mmol/l
0.8
1.9
1.04
37
260
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
67
1.81
1.05
1.2
1.3
nmol/l
0.6
0.6
0.08
12
60
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
593
1.26
1.05
2.4
2.7
umol/l
10.7
8.0
0.34
65
531
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
213
1.43
1.04
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
335
1.34
1.02
2.8
2.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
362
1.32
1.01
4.0
3.4
kpa
5.2
5.1
0.17
41
339
(3051651) Icteric interference index of Serum or Plasma
7
35
2.01
1.00
3.6
3.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
131
0.53
1.00
1.1
1.2
mg/l
444.7
521.6
—
7
123
(3011397) Hemoglobin [Presence] in Urine by Test strip
136
1186
1.19
0.99
4.4
3.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.3
—
70.6
—
0
8
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
116
0.51
0.95
1.2
1.2
mmol/l
3.4
3.8
—
6
109
(3017704) Immunofixation for Urine
7
37
1.90
0.94
2.4
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
27
2.23
0.93
1.5
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
6
27
2.23
0.93
1.2
1.1
—
4.8
—
0
9
(3037522) Nuclear Ab [Titer] in Serum
79
658
1.23
0.93
1.4
1.3
titre
609.2
489.7
0.24
13
149
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
28
2.15
0.91
1.5
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
28
2.15
0.91
1.5
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
280
1.34
0.91
1.1
1.2
iu/ml
226.8
133.2
0.69
14
112
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
135
1.50
0.90
1.9
1.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
6
29
2.08
0.89
1.2
1.1
—
0.9
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
8
42
1.92
0.89
6.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
56
1.80
0.88
2.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
56
1.80
0.88
2.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
56
1.80
0.88
2.6
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
145
1285
1.17
0.88
7.2
6.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
23
161
1.45
0.87
1.5
1.6
iu/ml
4.0
0.1
—
5
32
(3014133) Dog dander IgE Ab [Units/volume] in Serum
6
30
2.01
0.87
1.2
1.0
—
1.0
—
0
12
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
64
1.73
0.86
1.4
1.1
—
—
—
0
0
(44790047)
12
72
1.68
0.85
1.2
1.6
—
—
—
0
0
(44790049)
12
72
1.68
0.85
1.2
1.6
—
—
—
0
0
(44790048)
12
72
1.68
0.85
1.2
1.6
—
—
—
0
0
(44806118)
12
72
1.68
0.85
1.2
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
196
1.39
0.85
2.3
1.5
—
—
—
0
0
(4062490)
8
45
1.79
0.84
1.5
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
171
1.42
0.84
1.8
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
602
1.22
0.83
1.5
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
3.0
1.2
ug/l
8.7
6.4
—
6
27
(3000093) Morphology [Interpretation] in Blood Narrative
8
47
1.71
0.81
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
139
1.45
0.80
1.1
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
199
1.37
0.79
1.2
2.1
g/l
10.2
10.5
0.17
21
172
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
75
633
1.21
0.79
2.1
1.9
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
24
0.00
0.79
0.0
1.3
—
65.8
—
0
16
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
131
1.46
0.79
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
85
727
1.20
0.78
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
98
0.51
0.78
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
140
1.44
0.77
1.9
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
0
27
0.00
0.77
0.0
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
120
1351
0.86
0.76
3.9
3.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
83
1.58
0.75
4.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
116
1.48
0.75
1.8
1.2
—
—
—
0
0
(4211845)
5
24
2.09
0.74
5.6
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
107
0.56
0.73
2.7
3.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
60
1.68
0.72
1.4
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
26
1.93
0.70
2.6
1.4
umol/l
6.2
5.8
—
5
14
(3000475) Leukocytes [#/volume] in Synovial fluid
20
144
1.40
0.68
2.3
1.6
e6/l
14444.6
18477.6
0.25
14
108
(4094501)
20
144
1.40
0.68
1.1
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
4.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
4.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
4.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
4.0
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
93
814
1.17
0.67
1.3
1.3
u/ml
15.6
12.8
0.11
32
314
(3002256) Pathology report gross observation
75
645
1.19
0.67
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
348
0.77
0.65
1.8
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
87
1.50
0.63
4.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
79
1.53
0.63
1.0
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
101
0.59
0.62
2.8
2.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
124
1116
1.14
0.62
1.6
1.6
mg/l
1.4
1.3
0.13
95
872
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
156
1.36
0.61
1.6
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
139
1.38
0.61
5.1
4.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
88
1.49
0.61
4.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
88
1.49
0.61
4.4
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
163
0.67
0.60
3.4
5.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
51
1.58
0.60
1.3
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
22
0.00
0.59
0.0
1.2
—
1.2
—
0
16
(3004588) Protein electrophoresis panel - Serum or Plasma
48
401
1.21
0.59
3.4
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
166
1.34
0.59
1.3
1.4
ug/g
238.2
284.8
0.75
13
99
(3018095) Leukocytes [#/volume] in Urine
171
1849
0.90
0.58
3.8
3.8
e6/l
23.3
138.5
2.31
133
1340
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
89
1.47
0.58
1.2
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
115
1.40
0.57
2.0
2.1
g/l
117.9
127.2
0.87
11
85
(3019230) Fractional oxyhemoglobin in Venous blood
14
98
1.44
0.57
4.0
2.4
%
50.4
63.9
1.20
14
98
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
15
107
1.41
0.56
2.8
3.7
u/ml
44.9
437.8
1.04
15
102
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
65
1.55
0.55
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.6
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
116
1.39
0.55
1.4
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
60
1.51
0.54
2.7
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
277
1.24
0.54
1.3
1.3
—
—
—
0
0
(4146454)
9
62
1.46
0.53
2.9
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
39
1.54
0.53
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
39
1.54
0.53
1.2
1.1
—
0.4
—
0
9
(3003694) ABO and Rh group [Type] in Blood
137
1255
1.12
0.53
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
96
0.62
0.52
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
136
0.66
0.52
1.7
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
40
1.50
0.51
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
344
1.21
0.50
2.0
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
41
1.47
0.50
2.3
2.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
41
1.47
0.50
2.7
2.2
ug/l
4.0
2.1
—
6
35
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
41
1.47
0.50
1.5
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
410
0.82
0.50
3.6
4.1
%
1.1
0.4
0.94
11
108
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
101
1.40
0.50
2.1
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
284
2710
1.09
0.48
2.6
2.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.2
—
81.8
—
0
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
59
515
1.16
0.47
4.4
3.5
kpa
5.9
5.8
0.28
59
499
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
71
629
1.15
0.47
2.3
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
49
1.43
0.46
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
126
1159
1.11
0.46
1.7
1.7
pmol/l
458.7
437.0
0.35
101
946
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
112
1.35
0.45
1.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
69
1.46
0.44
3.0
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
135
1456
0.91
0.44
4.3
4.3
%
19.5
21.1
0.58
55
688
(3002032) Base excess in Venous blood by calculation
58
509
1.15
0.44
4.4
3.5
mmol/l
1.6
2.1
0.41
51
410
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
139
1.30
0.44
1.6
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
94
853
1.12
0.44
1.4
1.3
iu/ml
69.5
37.4
0.57
23
278
(3044927) Protein electrophoresis panel - Urine
11
78
1.42
0.43
1.4
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
78
1.42
0.43
1.4
1.1
—
—
—
0
0
(44813793)
5
31
1.62
0.43
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
122
1.32
0.42
4.4
2.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
87
1.39
0.42
2.6
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
94
0.63
0.42
1.3
2.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.0
1.3
promille
1.1
1.1
—
5
25
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
0.8
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
132
1.30
0.40
1.5
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
130
1398
0.91
0.40
3.5
3.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
174
1637
1.09
0.40
4.2
3.3
u/l
64.9
32.4
0.51
166
1558
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
60
1.34
0.40
1.5
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
18
0.00
0.40
0.0
5.6
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.1
—
10.8
—
0
9
(3002523) Influenza virus A Ag [Presence] in Specimen
8
61
1.32
0.39
1.5
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
34
397
0.85
0.38
3.8
4.3
%
0.2
0.1
0.38
12
112
(3000850) Epithelial cells [#/volume] in Urine
118
1094
1.10
0.38
2.8
2.6
e6/l
5.0
5.0
0.02
106
970
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
116
1.30
0.37
4.1
3.7
mg/l
19.6
28.9
—
9
72
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
37
427
0.86
0.36
3.7
4.2
%
0.3
0.2
0.41
17
135
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
81
1.36
0.36
1.2
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
79
0.63
0.35
3.2
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
80
0.62
0.35
2.0
2.8
—
—
—
0
0
(4034850)
13
167
0.77
0.35
27.0
10.9
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
44
1.37
0.34
1.0
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
49
550
0.88
0.34
3.4
3.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
45
1.34
0.34
1.0
1.1
nmol/l
1.4
1.6
—
6
40
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
205
1956
1.07
0.33
4.3
4.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
20
164
1.23
0.33
3.5
1.3
g/l
1.2
1.2
0.05
20
159
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
503
1.12
0.33
1.6
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
74
1.36
0.32
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
25
293
0.85
0.30
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
151
1592
0.93
0.30
3.5
3.3
e6/l
33.5
108.4
1.09
125
1240
(3018418) pH of Serum or Plasma
168
1598
1.07
0.30
5.5
4.0
ph
7.4
7.4
0.83
17
303
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
84
1.32
0.30
3.2
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
152
0.79
0.29
2.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
25
213
1.18
0.29
1.9
1.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
52
469
1.12
0.29
2.2
2.4
u/l
81.8
32.6
0.47
45
395
(40768800) Prostate Pathology biopsy report
8
110
0.72
0.29
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
491
1.11
0.27
1.7
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
352
0.87
0.26
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
29
253
1.15
0.26
3.7
3.4
u/ml
64.9
69.6
0.03
29
244
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
134
1410
0.94
0.26
1.9
1.6
mmol/l
1.4
1.4
0.13
122
1170
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
79
846
0.92
0.24
3.2
3.1
e6/l
2.1
2.3
0.17
54
475
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
189
1.17
0.24
6.9
3.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
313
1.13
0.23
1.1
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
110
1041
1.07
0.23
2.6
3.0
mmol/l
2.5
2.5
0.03
93
920
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
106
1.23
0.23
1.2
1.2
—
2.3
—
0
9
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
38
1.32
0.23
1.2
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
451
4443
1.06
0.23
20.7
16.3
%
38.1
39.6
1.73
263
3013
(3030467) Casts [#/volume] in Urine by Automated count
139
1454
0.94
0.22
3.5
3.2
e6/l
0.5
0.5
0.14
114
1102
(3044889) 12 lead EKG panel
376
3688
1.05
0.22
4.1
4.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
51
469
1.10
0.22
2.0
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.5
—
3.6
—
0
5
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
32.2
—
0
7
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
117
1.20
0.20
1.7
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
175
1813
0.95
0.20
4.6
4.9
ug/l
1.7
2.6
2.05
156
1614
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
111
0.81
0.20
1.6
1.6
—
—
—
0
0
(4024509)
6
49
1.23
0.20
1.7
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
231
1.13
0.20
1.1
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
128
1.18
0.18
1.5
1.9
nmol/l
37.9
41.5
0.31
15
123
(3024354) Oxygen [Partial pressure] in Venous blood
47
435
1.09
0.18
3.6
2.7
kpa
4.6
4.4
0.31
47
419
(3012441) Differential panel - Pleural fluid
7
58
1.21
0.18
1.9
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
43
464
0.92
0.17
1.9
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
69
1.16
0.16
1.8
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
71
1.13
0.16
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
287
0.90
0.16
2.5
4.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
80
0.75
0.15
2.8
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
109
1050
1.05
0.14
2.9
2.9
mosm/kgh2o
570.3
556.1
0.25
94
893
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
84
1.19
0.14
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
257
1.09
0.13
1.8
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
94
1.17
0.13
1.6
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
94
1.17
0.13
1.6
2.1
pmol/l
185.8
221.3
1.08
11
87
(3003338) MCHC [Mass/volume]
415
4105
1.03
0.13
27.7
20.1
g/l
332.5
332.1
0.49
410
4080
(3017181) Myelocytes/100 leukocytes in Blood
43
456
0.94
0.12
4.0
4.1
%
0.7
0.9
0.52
18
151
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
230
1.09
0.11
1.6
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
45
427
1.06
0.10
8.9
7.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
56
1.07
0.08
4.0
2.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
64
0.78
0.08
4.2
3.1
nmol/l
4.6
5.7
—
5
64
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
64
0.78
0.08
5.4
4.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
569
1.04
0.08
2.0
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
166
1.09
0.08
2.0
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
6
75
0.80
0.07
2.0
1.4
g/l
32.0
30.9
—
6
66
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
76
1.05
0.07
1.8
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
108
1.11
0.07
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
104
1064
0.97
0.07
5.2
4.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
304
1.06
0.07
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
84
1.07
0.07
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
88
1.02
0.07
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
89
1.13
0.07
1.9
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
14
129
1.09
0.05
1.1
1.2
—
2.8
—
0
18
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
478
4801
0.98
0.05
15.9
14.2
ml/min/173m2
78.1
77.2
0.42
409
3973
(3009261) Glucose [Presence] in Urine by Test strip
256
2539
1.01
0.04
4.2
3.8
estimate
0.0
0.0
0.50
22
450
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
109
0.92
0.04
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
200
1.05
0.04
1.7
3.0
g/l
0.3
0.2
—
5
79
(3029937) Albumin [Presence] in Urine by Test strip
136
1375
0.99
0.03
4.8
4.1
estimate
0.0
0.0
0.00
21
449
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
151
1.06
0.03
1.8
2.4
ug/min
56.4
91.3
—
7
90
(40768793) Breast Pathology biopsy report
14
132
1.06
0.02
1.2
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
27
279
0.97
0.02
4.6
3.2
mmol/l
25.4
25.1
0.14
27
271
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
16
167
0.96
0.01
1.8
1.7
mg/l
2.5
3.4
0.35
16
131
(3001019) Free T4 and TSH panel - Serum or Plasma
18
173
1.04
0.01
1.9
1.7
—
—
—
0
0
(1002224) Polysomnography panel
18
187
0.96
0.01
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
106
0.94
0.01
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
164
1.04
0.00
2.9
2.6
u/ml
0.4
0.3
0.07
11
90
(3049717) Cytology report of Urine Cyto stain
22
226
0.97
0.00
2.3
2.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
105
1.05
0.00
1.9
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
125
1.04
0.00
1.2
1.1
—
7.7
—
0
12
(3044941) Cell count panel - Synovial fluid
10
96
1.04
0.00
1.9
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
144
0.97
0.00
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
117
1.03
0.00
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
90
895
1.01
0.00
2.9
2.8
e6/l
0.9
1.1
0.35
65
521
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
14
138
1.01
0.00
1.1
1.2
—
22.0
—
0
7
(3034770) Mitochondria Ab [Titer] in Serum
15
148
1.01
0.00
1.2
1.2
—
741.7
—
0
6
(3021601) Nitrite [Presence] in Urine by Test strip
250
2505
1.00
0.00
5.6
5.2
estimate
0.0
0.0
0.00
25
458
(3045788) Cell count panel - Pleural fluid
5
50
1.00
0.00
1.6
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.0
1.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
85
0.94
0.00
3.0
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
76
0.92
0.00
1.4
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.9
—
0
7
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
84
0.95
0.00
3.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
66
0.91
0.00
1.5
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.6
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
1.9
—
0
7
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
84
0.95
0.00
1.0
1.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
77
0.91
0.00
1.7
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
250
2500
1.00
0.00
4.2
3.8
estimate
0.0
0.0
0.00
20
464
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ORAL_LEUCOPLACIA and mortality.

Females

Parameter HR [95% CI] p-value
K11_ORAL_LEUCOPLACIA 1.137 [1.0, 1.3] 0.059
Birth year 0.996 [0.99, 1.01] 0.414

During the follow-up period (1.1.1998 — 31.12.2019), 393 out of 1808 females with K11_ORAL_LEUCOPLACIA died.

Males

Parameter HR [95% CI] p-value
K11_ORAL_LEUCOPLACIA 1.285 [1.12, 1.48] < 0.001
Birth year 0.987 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 392 out of 1574 males with K11_ORAL_LEUCOPLACIA died.

Mortality risk

Mortality risk for people of age

years, who have K11_ORAL_LEUCOPLACIA.

N-year risk Females Males
1 0.131% 0.218%
5 0.745% 1.537%
10 1.697% 3.884%
15 3.304% 7.288%
20 5.854% 12.14%

Relationships between endpoints

↥

Index endpoint: K11_ORAL_LEUCOPLACIA – Oral leukoplakia

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data